Business Description
Level Bio AB
NAICS : 334517
SIC : 3844
ISIN : SE0000885501
Compare
Compare
Traded in other countries / regions
LEVBIO.Sweden4MB.Germany IPO Date
2006-09-15Description
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.09 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.7 | |||||
Beneish M-Score | -5.29 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.5 | |||||
3-Year Book Growth Rate | 42.2 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.01 | |||||
9-Day RSI | 42.69 | |||||
14-Day RSI | 45.76 | |||||
6-1 Month Momentum % | -36.03 | |||||
12-1 Month Momentum % | -47.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.46 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.48 | |||||
Days Inventory | 150.77 | |||||
Days Sales Outstanding | 60.81 | |||||
Days Payable | 50.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -2.78 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.76 | |||||
Operating Margin % | -46.67 | |||||
Net Margin % | -49.04 | |||||
FCF Margin % | -19.65 | |||||
ROE % | -82.01 | |||||
ROA % | -53.88 | |||||
ROIC % | -66.83 | |||||
ROC (Joel Greenblatt) % | -327.16 | |||||
ROCE % | -79.36 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.79 | |||||
PB Ratio | 2.29 | |||||
Price-to-Tangible-Book | 5.76 | |||||
EV-to-EBIT | -1.36 | |||||
EV-to-EBITDA | -1.68 | |||||
EV-to-Revenue | 0.68 | |||||
EV-to-FCF | -3.45 | |||||
Price-to-Projected-FCF | 14.4 | |||||
Price-to-Median-PS-Value | 0.26 | |||||
Price-to-Net-Current-Asset-Value | 7.2 | |||||
Earnings Yield (Greenblatt) % | -73.53 | |||||
FCF Yield % | -24.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Level Bio AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 23.199 | ||
EPS (TTM) (kr) | -0.187 | ||
Beta | -0.19 | ||
Volatility % | 41.05 | ||
14-Day RSI | 45.76 | ||
14-Day ATR (kr) | 0.038239 | ||
20-Day SMA (kr) | 0.3018 | ||
12-1 Month Momentum % | -47.33 | ||
52-Week Range (kr) | 0.12 - 0.79 | ||
Shares Outstanding (Mil) | 63.4 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Level Bio AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Level Bio AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Level Bio AB Frequently Asked Questions
What is Level Bio AB(XSAT:LEVBIO)'s stock price today?
The current price of XSAT:LEVBIO is kr0.29. The 52 week high of XSAT:LEVBIO is kr0.79 and 52 week low is kr0.12.
When is next earnings date of Level Bio AB(XSAT:LEVBIO)?
The next earnings date of Level Bio AB(XSAT:LEVBIO) is 2024-10-24.
Does Level Bio AB(XSAT:LEVBIO) pay dividends? If so, how much?
Level Bio AB(XSAT:LEVBIO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |